NeuroSense Therapeutics (NRSN) Q2 2025 Earnings

May 28Confirmed
Q3 2024
Q4 2024
Q2 2025
Q2 2025
-0.19
-0.14
-0.09
-0.04

Details

Expected EPS
-0.10425
Actual EPS
-0.10425
Surprise EPS
0
Surprise Percent
+0%

Description

⁨NeuroSense Therapeutics⁩ (⁦NRSN⁩) has reported earnings of ⁦-0.10425⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts